A Simple Test Could Cut Unnecessary Antibiotics in Kids With RSV—Here's Why That Matters

A new study shows that using rapid tests to diagnose respiratory syncytial virus (RSV) in young children reduces unnecessary antibiotic prescriptions by up to 48%, offering a practical solution to one of medicine's biggest problems: overuse of antibiotics. Researchers from the University of Milan-Bicocca found that when doctors could quickly confirm RSV was viral—not bacterial—they were far less likely to prescribe antibiotics that wouldn't help anyway.

Why Are Doctors Prescribing Antibiotics for a Virus?

RSV is a common respiratory virus that affects millions of young children each year. It causes about 50% to 80% of bronchiolitis cases in hospitalized children five years old and younger, and roughly 40% of pneumonia cases in children over 12 months. The problem is straightforward: antibiotics don't work against viruses, only bacteria. Yet despite clear medical guidelines stating this, doctors in outpatient settings—like pediatrician offices—frequently prescribe antibiotics for RSV anyway.

Why? Often because they can't immediately tell whether a child's respiratory infection is viral or bacterial. Without a quick diagnostic test, doctors face uncertainty and may prescribe antibiotics "just in case," even though the infection is almost certainly viral. This practice fuels antibiotic resistance, a growing threat that makes infections harder to treat.

What Did the Study Actually Show?

Researchers studied 256 children (median age 15 months) in Italy who had suspected lower respiratory tract infections. About 31% tested positive for RSV, while 69% tested negative. Here's what happened when doctors used rapid antigen diagnostic tests (Ag-RDTs)—quick tests that can detect RSV, COVID-19, and influenza in minutes:

• RSV-Positive Children: Received antibiotics at a rate of 0.18 prescriptions per 10 person-days
• RSV-Negative Children: Received antibiotics at a rate of 0.29 prescriptions per 10 person-days
• Overall Reduction: Detection of RSV by rapid test was linked to a 48% lower risk of receiving any antibiotic prescription

When researchers compared prescribing patterns before and after rapid tests were introduced, the results were even more striking. In the 2023-24 season, rapid test implementation was associated with a 39% reduction in antibiotic prescriptions. The year before, it was a 46% reduction.

How Can Rapid Tests Help Your Child's Care?

The mechanism is simple but powerful: when a rapid test confirms RSV is the culprit, doctors gain confidence in withholding antibiotics. "By improving diagnostic accuracy at the point of care, Ag-RDTs can support more targeted treatment decisions and strengthen antimicrobial stewardship," the study authors wrote. In other words, doctors can make smarter choices based on facts rather than guesswork.

This matters because unnecessary antibiotics carry real risks. They can cause side effects like allergic reactions and diarrhea, and they contribute to antibiotic resistance—a phenomenon where bacteria evolve to survive antibiotics, making future infections harder to treat. By reducing unnecessary prescriptions, rapid RSV tests protect both individual children and public health.

Steps to Advocate for Rapid Testing in Your Doctor's Office

• Ask About Testing: When your child has respiratory symptoms, ask your pediatrician if they can perform a rapid RSV test to confirm the diagnosis before prescribing antibiotics
• Understand the Results: If your child tests positive for RSV, expect your doctor to avoid antibiotics unless there's clear evidence of a secondary bacterial infection
• Request Documentation: Ask your doctor to note the test result in your child's medical record so future providers know RSV was confirmed

What Are the Limitations?

The study had some important caveats. It involved only 256 children in Italy, so researchers noted that larger studies are needed to confirm the findings apply broadly to other populations and settings. Additionally, the study couldn't account for disease severity—children with more serious infections might need antibiotics even if RSV is confirmed, and the role of rapid testing in severe cases remains unclear.

Carl Llor, a researcher from the University of Southern Denmark, noted in commentary accompanying the study that "the findings suggest that virologic confirmation can increase clinicians' confidence in withholding antibiotics when a viral etiology is identified, thereby supporting more judicious prescribing practices, particularly in nonserious cases". However, he emphasized that more research is needed to understand how rapid testing should guide treatment in more severe presentations.

Why This Matters Beyond Your Child's Doctor's Visit

Antibiotic resistance is a silent but serious threat. When bacteria develop resistance to antibiotics, infections that were once easily treatable become dangerous. By reducing unnecessary antibiotic use in children with RSV, rapid testing helps preserve the effectiveness of these life-saving drugs for cases where they're truly needed.

The widespread adoption of rapid diagnostic tools during the COVID-19 pandemic created an opportunity: these same tests can now diagnose RSV and influenza quickly and accurately. This study demonstrates that when doctors have access to rapid, accurate information, they make better prescribing decisions—without needing lectures or guidelines reminding them that antibiotics don't work against viruses.

As antibiotic resistance continues to grow as a global health threat, simple tools like rapid RSV tests offer a practical, evidence-based way to improve care while protecting public health. If your child develops respiratory symptoms, asking whether a rapid test is available could make a real difference.